Kayleigh R Marx

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Bariatric Surgery

Newly Diagnosed

Top Venues

Leukemia & lymphoma

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, Elias J Jabbour, Nicholas James Short, Jing Ning, Lianchun Xiao, Naveen Pemmaraju, Courtney D D DiNardo, Tapan Mahendra Kadia, Kayleigh R Marx, Guillermo Garcia Manero, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Association between bariatric surgery and outcomes in chronic myeloid leukemia. Cancer (2023)
Kayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, Nicholas James Short, Shilpa Paul, Nitin Jain, Jenessa Lee, J Michael Savoy, Farhad Ravandi, Elias J Jabbour
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals. Leukemia & lymphoma (2022)
Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, Courtney D Dinardo, Farhad Ravandi, Nicholas James Short, Michael Andreeff, Gautam Borthakur, Naval G Daver, Naveen Pemmaraju, Koiji Sasaki, Guillermo Montalban Bravo, Kayleigh R Marx, Sherry Pierce, Uday R Popat, Elizabeth J Shpall, Rashmi Kanagal-Shamana, Guillermo Garcia Manero, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy. Cancer 127 (19) (2021)